• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG-PET/MRI 纹理分析在新辅助放化疗后直肠癌中的应用。

18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy.

机构信息

General Surgery 3, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova.

Department of Mathematics, University of Genova, Genova.

出版信息

Nucl Med Commun. 2022 Jul 1;43(7):815-822. doi: 10.1097/MNM.0000000000001570. Epub 2022 Apr 26.

DOI:10.1097/MNM.0000000000001570
PMID:35471653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9177153/
Abstract

OBJECTIVE

Reliable markers to predict the response to neoadjuvant chemoradiotherapy (nCRT) in locally advanced rectal cancer (LARC) are lacking. We aimed to assess the ability of 18F-FDG PET/MRI to predict response to nCRT among patients undergoing curative-intent surgery.

METHODS

Patients with histological-confirmed LARC who underwent curative-intent surgery following nCRT and restaging with 18F-FDG PET/MRI were included. Statistical correlation between radiomic features extracted in PET, apparent diffusion coefficient (ADC) and T2w images and patients' histopathologic response to chemoradiotherapy using a multivariable logistic regression model ROC-analysis.

RESULTS

Overall, 50 patients were included in the study. A pathological complete response was achieved in 28.0% of patients. Considering second-order textural features, nine parameters showed a statistically significant difference between the two groups in ADC images, six parameters in PET images and four parameters in T2w images. Combining all the features selected for the three techniques in the same multivariate ROC curve analysis, we obtained an area under ROC curve of 0.863 (95% CI, 0.760-0.966), showing a sensitivity, specificity and accuracy at the Youden's index of 100% (14/14), 64% (23/36) and 74% (37/50), respectively.

CONCLUSION

PET/MRI texture analysis seems to represent a valuable tool in the identification of rectal cancer patients with a complete pathological response to nCRT.

摘要

目的

局部晚期直肠癌(LARC)缺乏可靠的标志物来预测新辅助放化疗(nCRT)的反应。我们旨在评估 18F-FDG PET/MRI 预测接受根治性手术的患者对 nCRT 反应的能力。

方法

纳入接受 nCRT 并进行 18F-FDG PET/MRI 分期后接受根治性手术且组织学证实为 LARC 的患者。使用多变量逻辑回归模型 ROC 分析,评估在 PET、表观扩散系数(ADC)和 T2w 图像中提取的放射组学特征与患者对放化疗的组织病理学反应之间的统计学相关性。

结果

总体而言,本研究共纳入 50 例患者。28.0%的患者达到病理完全缓解。考虑到二阶纹理特征,ADC 图像中有 9 个参数在两组之间存在统计学差异,PET 图像中有 6 个参数,T2w 图像中有 4 个参数。将三种技术中选择的所有特征结合到同一个多变量 ROC 曲线分析中,我们得到 ROC 曲线下面积为 0.863(95%CI,0.760-0.966),在 Youden 指数处的灵敏度、特异性和准确度分别为 100%(14/14)、64%(23/36)和 74%(37/50)。

结论

PET/MRI 纹理分析似乎是一种有价值的工具,可以识别出对 nCRT 具有完全病理缓解的直肠癌患者。

相似文献

1
18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy.18F-FDG-PET/MRI 纹理分析在新辅助放化疗后直肠癌中的应用。
Nucl Med Commun. 2022 Jul 1;43(7):815-822. doi: 10.1097/MNM.0000000000001570. Epub 2022 Apr 26.
2
Predicting locally advanced rectal cancer response to neoadjuvant therapy with F-FDG PET and MRI radiomics features.利用 F-FDG PET 和 MRI 放射组学特征预测局部进展期直肠癌对新辅助治疗的反应。
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):878-888. doi: 10.1007/s00259-018-4250-6. Epub 2019 Jan 13.
3
Diffusion-weighted MRI and F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.弥散加权 MRI 联合 F-FDG PET/CT 评估局部进展期食管鳞癌新辅助放化疗疗效
Radiat Oncol. 2021 Jul 19;16(1):132. doi: 10.1186/s13014-021-01852-z.
4
MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC).基于 MRI T2 加权序列的纹理分析(TA)作为预测局部晚期直肠癌(LARC)患者新辅助放化疗(nCRT)反应的指标。
Radiol Med. 2020 Dec;125(12):1216-1224. doi: 10.1007/s11547-020-01215-w. Epub 2020 May 14.
5
Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation.联合多参数 MRI 和 FDG-PET/CT 在新辅助放化疗前识别有良好反应的直肠癌患者的价值。
Eur Radiol. 2020 May;30(5):2945-2954. doi: 10.1007/s00330-019-06638-2. Epub 2020 Feb 7.
6
[Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].[MRI肿瘤退缩分级与表观扩散系数联合预测局部晚期直肠癌新辅助治疗后病理完全缓解的价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Apr 25;24(4):359-365. doi: 10.3760/cma.j.cn.441530-20200225-00089.
7
Value of perfusion parameters from golden-angle radial sparse parallel dynamic contrast-enhanced magnetic resonance imaging in predicting pathological complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.基于金角放射状稀疏并行动态对比增强磁共振成像的灌注参数预测局部进展期直肠癌新辅助放化疗后病理完全缓解的价值。
Diagn Interv Radiol. 2024 Jul 8;30(4):228-235. doi: 10.4274/dir.2024.232460. Epub 2024 Mar 26.
8
MRI-Based Radiomic Models Outperform Radiologists in Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.MRI 基放射组学模型在预测局部晚期直肠癌新辅助放化疗病理完全缓解方面优于放射科医生。
Acad Radiol. 2023 Sep;30 Suppl 1:S176-S184. doi: 10.1016/j.acra.2022.12.037. Epub 2023 Feb 2.
9
Response assessment of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Is apparent diffusion coefficient useful on 3 T magnetic resonance imaging?局部进展期直肠癌新辅助放化疗后疗效评估:3.0T 磁共振弥散加权成像表观弥散系数是否有用?
Colorectal Dis. 2023 May;25(5):905-915. doi: 10.1111/codi.16483. Epub 2023 Feb 20.
10
Value of volumetric and textural analysis in predicting the treatment response in patients with locally advanced rectal cancer.容积和纹理分析在预测局部晚期直肠癌患者治疗反应中的价值。
Ann Nucl Med. 2020 Dec;34(12):960-967. doi: 10.1007/s12149-020-01527-x. Epub 2020 Sep 19.

引用本文的文献

1
Correlation Between MRI and Histopathology in Assessing Treatment Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.磁共振成像(MRI)与组织病理学在评估局部晚期直肠癌新辅助放化疗治疗反应中的相关性
Cancer Rep (Hoboken). 2025 Sep;8(9):e70322. doi: 10.1002/cnr2.70322.
2
MRI radiomics prediction modelling for pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review and meta-analysis.局部晚期直肠癌新辅助放化疗病理完全缓解的MRI影像组学预测模型:一项系统评价和荟萃分析
Abdom Radiol (NY). 2025 Apr 28. doi: 10.1007/s00261-025-04953-5.
3
A Machine Learning Model Based on MRI Radiomics to Predict Response to Chemoradiation Among Patients with Rectal Cancer.
一种基于MRI影像组学的机器学习模型,用于预测直肠癌患者对放化疗的反应。
Life (Basel). 2024 Nov 22;14(12):1530. doi: 10.3390/life14121530.
4
CLIP-based multimodal endorectal ultrasound enhances prediction of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.基于CLIP的多模态腔内直肠超声可增强局部晚期直肠癌新辅助放化疗反应的预测。
PLoS One. 2024 Dec 11;19(12):e0315339. doi: 10.1371/journal.pone.0315339. eCollection 2024.
5
FDG-PET/MRI in colorectal cancer care: an updated systematic review.氟代脱氧葡萄糖正电子发射断层扫描/磁共振成像在结直肠癌治疗中的应用:一项更新的系统评价
Abdom Radiol (NY). 2025 Jan;50(1):49-63. doi: 10.1007/s00261-024-04460-z. Epub 2024 Jul 29.
6
Clinical significance of the maximum standardized uptake value on positron emission tomography to predict treatment response and outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy.正电子发射断层扫描中最大标准化摄取值对预测接受新辅助放化疗的直肠癌患者治疗反应和结局的临床意义。
Surg Today. 2025 Feb;55(2):154-161. doi: 10.1007/s00595-024-02880-4. Epub 2024 Jun 15.
7
Medical Radiology: Current Progress.医学放射学:当前进展
Diagnostics (Basel). 2023 Jul 21;13(14):2439. doi: 10.3390/diagnostics13142439.
8
A primer on rectal MRI in patients on watch-and-wait treatment for rectal cancer.直肠癌患者等待观察治疗时的直肠 MRI 入门。
Abdom Radiol (NY). 2023 Sep;48(9):2836-2873. doi: 10.1007/s00261-023-03900-6. Epub 2023 Apr 26.
9
Radiomics Approaches for the Prediction of Pathological Complete Response after Neoadjuvant Treatment in Locally Advanced Rectal Cancer: Ready for Prime Time?基于影像组学方法预测局部晚期直肠癌新辅助治疗后的病理完全缓解:已准备好进入黄金时代了吗?
Cancers (Basel). 2023 Jan 9;15(2):432. doi: 10.3390/cancers15020432.
10
FDG-PET/MRI for Nonoperative Management of Rectal Cancer: A Prospective Pilot Study.FDG-PET/MRI 用于直肠癌的非手术治疗管理:一项前瞻性的初步研究。
Tomography. 2022 Nov 9;8(6):2723-2734. doi: 10.3390/tomography8060227.